Experts discuss breast cancer treatment updates at the 2020 San Antonio Breast Cancer Symposium virtual conference.
Chemotherapy With Endocrine Therapy Shows Clinical Benefit With Improved Survival in Breast Cancer
Premenopausal women with HR-positive, HER2-negative, lymph node-positive breast cancer and a risk for recurrence experienced benefits with chemotherapy plus endocrine therapy, with improvements in five-year invasive disease-free and overall survival.
Verzenio Continues to Show Reduced Risk in Invasive Disease-Free Survival in High-Risk Early HR+ Breast Cancer
In this phase 3 trial, Verzenio with endocrine therapy reduced the risk for invasive disease recurrence and death versus endocrine therapy alone for patients with high-risk, early hormone receptor–positive, HER2-negative breast cancer.
Meditation, Survivorship Classes Significantly Reduced Depressive Symptoms in Young Breast Cancer Survivors
Prior to receiving behavioral interventions, more than half of participating young survivors of breast cancer were considered clinically depressed. That number dropped to 30% after participants received mindfulness meditation and survivorship education classes.
Dietary Changes to Reduce Diabetes Risk May Also Increase Survival for Breast Cancer
Women with higher diet adherence scores after diagnosis had a 33% lower risk for all-cause mortality and a 17% lower risk for mortality related to breast cancer compared with women with lower diet adherence scores.
Physicians ‘Systematically’ Miss Substantial Symptoms in Certain Patients With Breast Cancer
Of note, the results indicated that patients with breast cancer who were younger than 60 and of Black or other race were more likely to experience under-recognized symptoms by their physician.
Women With Breast Cancer Who Receive Mastectomy and Reconstructive Surgery at Greater Risk for Continued Opioid, Controlled Substance Use
Younger age, breast cancer diagnosis, Medicaid insurance and treatment type were associated with an increased risk for women becoming new chronic users of opioids or sedatives/hypnotics following mastectomy with reconstructive surgery.
2 Commerce Drive Cranbury, NJ 08512